Atlas Trials

Thalidomide and Procarbazine in Treating Patients With Recurrent or Progressive Malignant Glioma

Clinical trial NCT00079092 · COMPLETED

Trial details

NCT number
NCT00079092
Sponsor
Wake Forest University Health Sciences
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Brain and Central Nervous System Tumors
Start date
2004-01-01
Primary completion
2006-03-21
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.